Compare LCNB & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LCNB | SWKH |
|---|---|---|
| Founded | 1877 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Diversified Financial Services |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 238.1M | 205.9M |
| IPO Year | 1999 | N/A |
| Metric | LCNB | SWKH |
|---|---|---|
| Price | $17.18 | $16.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | ★ 19.9K | 5.5K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 5.15% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.23 | N/A |
| Revenue | ★ $6,445,000.00 | N/A |
| Revenue This Year | $8.50 | $52.93 |
| Revenue Next Year | $3.66 | N/A |
| P/E Ratio | $14.00 | ★ $9.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.34 | $13.00 |
| 52 Week High | $17.89 | $18.66 |
| Indicator | LCNB | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 46.05 | 31.62 |
| Support Level | $16.45 | $16.15 |
| Resistance Level | $17.79 | $17.08 |
| Average True Range (ATR) | 0.33 | 0.24 |
| MACD | -0.07 | -0.08 |
| Stochastic Oscillator | 14.61 | 9.28 |
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.